> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Explains New LabelComp Tool
- URL: https://www.fdaweb.com/fda-explains-new-labelcomp-tool/
- Published: 2024-08-01T12:00:00.000Z
- Updated: 2026-09-14T14:37:09.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157485

FDA researchers are using an open-source article in *Drug Safety* to introduce LabelComp, an artificial intelligence (AI) tool that automates the identification of changes in adverse event terms made during drug labeling updates. The [article](https://link.springer.com/article/10.1007/s40264-024-01468-8?ref=fdaweb.com) says that traditional methods of updating drug labeling with new adverse event information have been manual, time-consuming, and error-prone.

The researchers say LabelComp uses a combination of text analytics and a trained Bidirectional Encoder Representations from Transformers model to automatically identify changes in adverse event terms from updated drug labeling documents.

“The LabelComp AI tool was validated and demonstrated high accuracy and thus is a fit-for-purpose tool for the identification of adverse event changes in drug labeling that can enhance regulatory science research and characterization of adverse event profiles over time,” the article says.